Ex vivo programming of dendritic cells by mitochondria-targeted nanoparticles to produce interferon-gamma for cancer immunotherapy

ACS Nano

Volumn 7, Issue 8, 2013, Pages 7392-7402

  Marrache, Sean ^a   Tundup, Smanla ^a   Harn, Donald A ^a   Dhar, Shanta ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

apoptosis; biodegradable polymer; dendritic cell therapy; photodynamic therapy; vaccine

Indexed keywords

BREAST CANCER CELLS; CANCER IMMUNOTHERAPY; CLINICAL APPLICATION; DENDRITIC CELL THERAPY; HOST IMMUNE RESPONSE; IMMUNOTHERAPEUTIC; NATURAL KILLER CELLS; ZINC PHTHALOCYANINES;

ANTIBIOTICS; ANTIGENS; BIODEGRADABLE POLYMERS; CELL DEATH; DISEASES; NANOPARTICLES; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS; TUMORS; VACCINES; ZINC COMPOUNDS;

GLYCOPROTEINS;

BIOMATERIAL; CANCER VACCINE; GAMMA INTERFERON; INDOLE DERIVATIVE; NANOPARTICLE; ORGANOMETALLIC COMPOUND; PHOTOSENSITIZING AGENT; POLYMER; TUMOR ANTIGEN; ZN(II) PHTHALOCYANINE; ZN(II)-PHTHALOCYANINE;

ANIMAL; APOPTOSIS; ARTICLE; C57BL MOUSE; CELL STRAIN MCF 7; CHEMISTRY; CYTOLOGY; DENDRITIC CELL; DRUG EFFECT; HELA CELL; HUMAN; IMMUNOTHERAPY; METABOLISM; METHODOLOGY; MITOCHONDRION; MOUSE; NECROSIS; NEOPLASM; TUMOR CELL LINE; DRUG EFFECTS; HELA CELL LINE; MCF 7 CELL LINE; NEOPLASMS; PROCEDURES;

ANIMALS; ANTIGENS, NEOPLASM; APOPTOSIS; BIOCOMPATIBLE MATERIALS; CANCER VACCINES; CELL LINE, TUMOR; DENDRITIC CELLS; HELA CELLS; HUMANS; IMMUNOTHERAPY; INDOLES; INTERFERON-GAMMA; MCF-7 CELLS; MICE; MICE, INBRED C57BL; MITOCHONDRIA; NANOPARTICLES; NECROSIS; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; PHOTOSENSITIZING AGENTS; POLYMERS;

EID: 84883136637     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn403158n     Document Type: Article

References (45)

1. Swann, J. B.; Smyth, M. J. Immune Surveillance of Tumors J. Clin. Invest. 2007, 117, 1137-1146
2. Mellman, I.; Coukos, G.; Dranoff, G. Cancer Immunotherapy Comes of Age Nature 2011, 480, 480-489
3. Tacken, P. J.; de Vries, I. J. M.; Torensma, R.; Figdor, C. G. Dendritic-Cell Immunotherapy: From ex Vivo Loading to in Vivo Targeting Nat. Rev. Immunol. 2007, 7, 790-802
4. Timmerman, J. M.; Levy, R. Dendritic Cell Vaccines for Cancer Immunotherapy Annu. Rev. Med. 1999, 50, 507-529
5. Chang, D. H.; Dhodapkar, M. V. Dendritic Cells and Immunotherapy for Cancer Int. J. Hematol. 2003, 77, 439-443
6. Nestle, F. O.; Farkas, A.; Conrad, C. Dendritic-Cell-Based Therapeutic Vaccination against Cancer Curr. Opin. Immunol. 2005, 17, 163-169
7. Garg, A. D.; Nowis, D.; Golab, J.; Agostinis, P. Photodynamic Therapy: Illuminating the Road from Cell Death towards Anti-Tumour Immunity Apoptosis 2010, 15, 1050-1071
8. Castano, A. P.; Mroz, P.; Hamblin, M. R. Photodynamic Therapy and Anti-Tumour Immunity Nat. Rev. Cancer 2006, 6, 535-545
9. Marrache, S.; Choi, J. H.; Tundup, S.; Zaver, D.; Harn, D. A.; Dhar, S. Immune Stimulating Photoactive Hybrid Nanoparticles for Metastatic Breast Cancer Integr. Biol. 2013, 5, 215-223
10. Farokhzad, O. C.; Jon, S. Y.; Khademhosseini, A.; Tran, T. N. T.; LaVan, D. A.; Langer, R. Nanoparticle-Aptamer Bioconjugates: A New Approach for Targeting Prostate Cancer Cells Cancer Res. 2004, 64, 7668-7672
11. Farokhzad, O. C.; Cheng, J.; Teply, B. A.; Sherifi, I.; Jon, S.; Kantoff, P. W.; Richie, J. P.; Langer, R. Targeted Nanoparticle-Aptamer Bioconjugates for Cancer Chemotherapy in Vivo Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 6315-6320
12. Soppimath, K. S.; Aminabhavi, T. M.; Kulkarni, A. R.; Rudzinski, W. E. Biodegradable Polymeric Nanoparticles as Drug Delivery Devices J. Controlled Release 2001, 70, 1-20
13. Gu, F.; Zhang, L.; Teply, B. A.; Mann, N.; Wang, A.; Radovic-Moreno, A. F.; Langer, R.; Farokhzad, O. C. Precise Engineering of Targeted Nanoparticles by Using Self-Assembled Biointegrated Block Copolymers Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 2586-2591
14. Dhar, S.; Kolishetti, N.; Lippard, S. J.; Farokhzad, O. C. Targeted Delivery of a Cisplatin Prodrug for Safer and More Effective Prostate Cancer Therapy in Vivo Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 1850-1855
15. Marrache, S.; Dhar, S. Biodegradable Synthetic High-Density Lipoprotein Nanoparticles for Atherosclerosis Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 9445-9450
16. Marrache, S.; Pathak, R. K.; Darley, K. L.; Choi, J. H.; Zaver, D.; Kolishetti, N.; Dhar, S. Nanocarriers for Tracking and Treating Diseases Curr. Med. Chem. 2013, 20, 3500-3514
17. Smith, R. A. J.; Porteous, C. M.; Gane, A. M.; Murphy, M. P. Delivery of Bioactive Molecules to Mitochondria in Vivo Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 5407-5412
18. Marrache, S.; Dhar, S. Engineering of Blended Nanoparticle Platform for Delivery of Mitochondria-Acting Therapeutics Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 16288-16293
19. Redmond, R. W.; Kochevar, I. E. Spatially Resolved Cellular Responses to Singlet Oxygen Photochem. Photobiol. 2006, 82, 1178-1186
20. Skovsen, E.; Snyder, J. W.; Lambert, J. D.; Ogilby, P. R. Lifetime and Diffusion of Singlet Oxygen in a Cell J. Phys. Chem. B 2005, 109, 8570-8573
21. Dhar, S.; Gu, F. X.; Langer, R.; Farokhzad, O. C.; Lippard, S. J. Targeted Delivery of Cisplatin to Prostate Cancer Cells by Aptamer Functionalized Pt(IV) Prodrug-PLGA-PEG Nanoparticles Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 17356-17361
22. Kolishetti, N.; Dhar, S.; Valencia, P. M.; Lin, L. Q.; Karnik, R.; Lippard, S. J.; Langer, R.; Farokhzad, O. C. Engineering of Self-Assembled Nanoparticle Platform for Precisely Controlled Combination Drug Therapy Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 17939-17944
23. Floridi, A.; Paggi, M. G.; Marcante, M. L.; Silvestrini, B.; Caputo, A.; Demartino, C. Lonidamine, a Selective Inhibitor of Aerobic Glycolysis of Murine Tumor Cells J. Natl. Cancer I 1981, 66, 497-499
24. Davis, S.; Weiss, M. J.; Wong, J. R.; Lampidis, T. J.; Chen, L. B. Mitochondrial and Plasma Membrane Potentials Cause Unusual Accumulation and Retention of Rhodamine 123 by Human Breast Adenocarcinoma-Derived MCF-7 Cells J. Biol. Chem. 1985, 260, 13844-13850
25. Chen, L. B. Mitochondrial Membrane Potential in Living Cells Annu. Rev. Cell. Biol. 1988, 4, 155-181
26. Steinman, R. M.; Inaba, K.; Turley, S.; Pierre, P.; Mellman, I. Antigen Capture, Processing, and Presentation by Dendritic Cells: Recent Cell Biological Studies Hum. Immunol. 1999, 60, 562-567
27. Buytaert, E.; Dewaele, M.; Agostinis, P. Molecular Effectors of Multiple Cell Death Pathways Initiated by Photodynamic Therapy BBA-Rev. Cancer 2007, 1776, 86-107
28. Mroz, P.; Hashmi, J. T.; Huang, Y. Y.; Lange, N.; Hamblin, M. R. Stimulation of Anti-tumor Immunity by Photodynamic Therapy Expert Rev. Clin. Immunol. 2011, 7, 75-91
29. Papadakis, K. A.; Prehn, J. L.; Landers, C.; Han, Q. W.; Luo, X.; Cha, S. C.; Wei, P.; Targan, S. R. TL1A Synergizes with IL-12 and IL-18 to Enhance IFN-Gamma Production in Human T Cells and NK Cells J. Immunol. 2004, 172, 7002-7007
30. Tominaga, K.; Yoshimoto, T.; Torigoe, K.; Kurimoto, M.; Matsui, K.; Hada, T.; Okamura, H.; Nakanishi, K. IL-12 Synergizes with IL-18 or IL-1 beta for IFN-Gamma Production from Human T Cells Int. Immunol. 2000, 12, 151-160
31. Fricke, I.; Mitchell, D.; Mittelstadt, J.; Lehan, N.; Heine, H.; Goldmann, T.; Bohle, A.; Brandau, S. Mycobacteria Induce IFN-Gamma Production in Human Dendritic Cells via Triggering of TLR2 J. Immunol. 2006, 176, 5173-5182
32. Oliver, R. T. D.; Nouri, A. M. E. T Cell Immune Response to Cancer in Humans and Its Relevance for Immunodiagnosis and Therapy Cancer Surv. 1992, 13, 173-204
33. Mokyr, M. B.; Dray, S. Interplay between the Toxic Effects of Anticancer Drugs and Host Antitumor Immunity in Cancer Therapy Cancer Invest. 1987, 5, 31-38
34. Menard, C.; Martin, F.; Apetoh, L.; Bouyer, F.; Ghiringhelli, F. Cancer Chemotherapy: Not Only a Direct Cytotoxic Effect, but Also an Adjuvant for Antitumor Immunity Cancer Immunol. Immunother. 2008, 57, 1579-1587
35. Mattarollo, S. R.; Loi, S.; Duret, H.; Ma, Y.; Zitvogel, L.; Smyth, M. J. Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors Cancer Res. 2011, 71, 4809-4820
36. Robinson, C. M.; O'Dee, D.; Hamilton, T.; Nau, G. J. Cytokines Involved in Interferon-Gamma Production by Human Macrophages J. Innate Immun. 2010, 2, 56-65
37. Darwich, L.; Coma, G.; Pena, R.; Bellido, R.; Blanco, E. J.; Este, J. A.; Borras, F. E.; Clotet, B.; Ruiz, L.; Rosell, A. et al. Secretion of Interferon-Gamma by Human Macrophages Demonstrated at the Single-Cell Level after Costimulation with Interleukin (IL)-12 Plus IL-18 Immunology 2009, 126, 386-393
38. Gardella, S.; Andrei, C.; Costigliolo, S.; Poggi, A.; Zocchi, M. R.; Rubartelli, A. Interleukin-18 Synthesis and Secretion by Dendritic Cells Are Modulated by Interaction with Antigen-Specific T Cells J. Leukocyte Biol. 1999, 66, 237-241
39. Dreher, D.; Kok, M.; Obregon, C.; Kiama, S. G.; Gehr, P.; Nicod, L. P. Salmonella Virulence Factor SipB Induces Activation and Release of IL-18 in Human Dendritic Cells J. Leukocyte Biol. 2002, 72, 743-751
40. Mooney, L. M.; Al-Sakkaf, K. A.; Brown, B. L.; Dobson, P. R. Apoptotic Mechanisms in T47D and MCF-7 Human Breast Cancer Cells Br. J. Cancer 2002, 87, 909-917
41. Benjamin, C. W.; Hiebsch, R. R.; Jones, D. A. Caspase Activation in MCF7 Cells Responding to Etoposide Treatment Mol. Pharmacol. 1998, 53, 446-50
42. Banchereau, J.; Briere, F.; Caux, C.; Davoust, J.; Lebecque, S.; Liu, Y. T.; Pulendran, B.; Palucka, K. Immunobiology of Dendritic Cells Annu. Rev. Immunol. 2000, 18, 767-811
43. de Vries, I. J. M.; Lesterhuis, W. J.; Scharenborg, N. M.; Engelen, L. P. H.; Ruiter, D. J.; Gerritsen, M. J. P.; Croockewit, S.; Britten, C. M.; Torensma, R.; Adema, G. J. et al. Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients Clin. Cancer Res. 2003, 9, 5091-5100
44. Dhodapkar, M. V.; Steinman, R. M.; Krasovsky, J.; Munz, C.; Bhardwaj, N. Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells J. Exp. Med. 2001, 193, 233-238
45. Lanzavecchia, A.; Sallusto, F. Regulation of T Cell Immunity by Dendritic Cells Cell 2001, 106, 263-266